Earnings History Data for Pacific Biosciences of California, Inc. (PACB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		PACB	Pacific Biosciences of California, Inc.	694.95	-0.17	-0.20	-0.27	Pacific Biosciences of California Non-GAAP EPS of -$0.17 beats by $0.05, revenue of $40M misses by $1.86M [11/7/2024 4:19 PM]	2.31	-0.14 (-5.51%)	2.16	-0.29 (-11.83%)	1.16 - 10.65	25,682,817	10,770,000	272,038
Pacific Biosciences of California Non-GAAP EPS of -$0.17 beats by $0.05, revenue of $40M misses by $1.86M [11/7/2024 4:19 PM] PacBio announces private convertible exchange transaction of 1.50% convertible senior notes due 2028 [11/7/2024 4:19 PM] PacBio stock falls 16% post-market after Q3 revenue miss [11/7/2024 5:11 PM] PacBio Announces Third Quarter 2024 Financial Results [2024-11-07 04:05PM] PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 [2024-11-07 04:03PM] PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop [Nov-06-24 10:35PM] Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To Expect [Nov-06-24 07:30AM]
07-08-2024	AH		PACB	Pacific Biosciences of California, Inc.	454.83	-0.20	-0.24	-0.26	Pacific Biosciences of California Non-GAAP EPS of -$0.20 beats by $0.02, revenue of $36.01M misses by $5.01M [8/7/2024 4:22 PM]	1.65	0.12 (8.01%)	1.37	-0.16 (-10.46%)	1.16 - 12.53	10,762,430	10,260,000	197,004
Pacific Biosciences of California Non-GAAP EPS of -$0.20 beats by $0.02, revenue of $36.01M misses by $5.01M [8/7/2024 4:22 PM]
09-05-2024	AH		PACB	Pacific Biosciences of California, Inc.	501.07	-0.26	-0.26	-0.31	Pacific Biosciences of California Non-GAAP EPS of -$0.26 in-line, revenue of $38.81M misses by $3.23M [5/9/2024 4:09 PM]	1.77	0.05 (3.20%)	1.68	-0.04 (-2.33%)	1.25 - 14.55	12,025,106	10,760,000	146,523
Pacific Biosciences of California files to sell 10.55M shares of common stock for holders [5/9/2024 4:52 PM] Pacific Biosciences of California Non-GAAP EPS of -$0.26 in-line, revenue of $38.81M misses by $3.23M [5/9/2024 4:09 PM]
15-02-2024	AH		PACB	Pacific Biosciences of California, Inc.	1,630	-0.27	-0.31	-0.35	Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.01, revenue of $58.36M in-line [2/15/2024 4:10 PM]	5.73	-0.94 (-14.09%)	6.40	-0.27 (-4.05%)	5.68 - 14.55	16,757,655	6,930,000	69,406
Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.01, revenue of $58.36M in-line [2/15/2024 4:10 PM]
30-10-2023	AH		PACB	Pacific Biosciences of California, Inc.	1,790	-0.27	-0.30	-0.32	Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.02, revenue of $55.69M beats by $7.06M [10/30/2023 4:04 PM]	6.13	-0.98 (-13.71%)	6.80	-0.31 (-4.36%)	6.13 - 14.55	11,831,356	4,420,000	110,518
Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.02, revenue of $55.69M beats by $7.06M [10/30/2023 4:04 PM]
02-08-2023	AH		PACB	Pacific Biosciences of California, Inc.	3,300	-0.26	-0.34	-0.34	Pacific Biosciences of California Non-GAAP EPS of -$0.26 beats by $0.05, revenue of $47.57M beats by $7.66M [8/2/2023 4:11 PM]	11.51	-1.01 (-8.07%)	12.75	0.23 (1.84%)	4.77 - 14.55	8,762,713	3,540,000	78,244
Pacific Biosciences of California Non-GAAP EPS of -$0.26 beats by $0.05, revenue of $47.57M beats by $7.66M [8/2/2023 4:11 PM] PacBio buying Apton Biosystems in up to $110M deal [8/2/2023 4:30 PM] PacBio up 5% after hours on narrowing quarterly EPS loss, consensus beats [8/2/2023 4:56 PM]
02-05-2023	AH	4:05 PM ET (May 2)	PACB	Pacific Biosciences of California, Inc.	2,490	-0.31	-0.33	-0.37	Pacific Biosciences of California GAAP EPS of -$0.36 misses by $0.03, revenue of $38.9M beats by $4.52M [5/2/2023 4:03 PM]	11.73	0.43 (3.85%)	11.26	-0.04 (-0.35%)	3.85 - 14.20	7,415,175	2,980,000	2,269
Pacific Biosciences of California GAAP EPS of -$0.36 misses by $0.03, revenue of $38.9M beats by $4.52M [5/2/2023 4:03 PM] PacBio sees quarterly net loss widen as it misses on bottom line [5/2/2023 4:47 PM]
16-02-2023	AH	4:05 PM ET (Feb 16)	PACB	Pacific Biosciences of California, Inc.	2,530	-0.35	-0.34	-0.30	Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M [2/16/2023 4:04 PM]	10.45	-0.35 (-3.24%)	10.55	-0.25 (-2.31%)	3.85 - 14.20	4,808,159	3,790,000	5,540
Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M [2/16/2023 4:04 PM]
07-11-2022	AH	4:05 PM ET (Nov 7)	PACB	Pacific Biosciences of California, Inc.	1,780	-0.32	-0.35	-0.23	Pacific Biosciences of California Non-GAAP EPS of -$0.32 beats by $0.01, revenue of $32.31M misses by $3.09M [11/7/2022 4:08 PM]	9.00	0.58 (6.89%)	7.95	-0.47 (-5.58%)	3.85 - 29.94	9,346,112	6,870,000	22,658
Pacific Biosciences of California Non-GAAP EPS of -$0.32 beats by $0.01, revenue of $32.31M misses by $3.09M [11/7/2022 4:08 PM] PacBio beats on bottom line in Q3 even as net loss widens 8% YoY [11/7/2022 6:44 PM]
03-08-2022	AH	4:00 PM ET (Aug 3)	PACB	Pacific Biosciences of California, Inc.	1,000.00	-0.34	-0.34	-0.21	Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M [8/3/2022 5:20 PM]	5.82	0.61 (11.61%)	4.89	-0.32 (-6.14%)	3.85 - 35.58	13,887,784	5,700,000	25,752
Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M [8/3/2022 5:20 PM] PacBio Announces Second Quarter 2022 Financial Results [Aug-03-22 04:05PM]
04-05-2022	AH	4:05 PM ET (May 4)	PACB	Pacific Biosciences of California	1,422	-0.37	-0.32	0.00	Pacific Biosciences of California GAAP EPS of -$0.37 misses by $0.05, revenue of $33.17M beats by $0.35M [5/4/2022 4:06 PM]	6.38	-0.91 (-12.55%)	7.53	0.24 (3.29%)	5.91 - 36.36	8,461,559	7,460,000	55,653
Pacific Biosciences of California GAAP EPS of -$0.37 misses by $0.05, revenue of $33.17M beats by $0.35M [5/4/2022 4:06 PM] PacBio quarterly net loss narrows 7% but misses on the bottom line [5/4/2022 6:39 PM] Pacific Biosciences stock falls 8% as Cantor Fitzgerald cuts price target [5/5/2022 1:09 PM] PacBio Announces First Quarter 2022 Financial Results [May-04-22 04:03PM] Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates [May-04-22 06:05PM] PacBio's (PACB) Q1 Earnings Miss Estimates, Revenues Beat [May-05-22 10:54AM] Pacific Biosciences Clocks 14% Jump In Q1 Revenues [May-05-22 09:50AM]
15-02-2022	AH	4:05 PM ET (Feb 15)	PACB	Pacific Biosciences of California, Inc.	2,480	-0.30	-0.28	-0.01	Pacific Biosciences of California Non-GAAP EPS of -$0.30 misses by $0.01, revenue of $36M in-line [2/15/2022 4:09 PM]	11.89	0.51 (4.48%)	10.26	-1.12 (-9.84%)	9.04 - 51.25	9,791,828	4,460,000	80,930
Pacific Biosciences of California Non-GAAP EPS of -$0.30 misses by $0.01, revenue of $36M in-line [2/15/2022 4:09 PM] Pacific Biosciences price target lowered on Wall Street after Q4 2021 earnings [2/16/2022 9:29 AM] PacBio Announces Fourth Quarter and Fiscal Year 2021 Financial Results [Feb-15-22 04:05PM] Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates [Feb-15-22 05:55PM] KK Womens and Childrens Hospital and PacBio Collaborate in Asias First Study of Unexplained Neurodevelopmental Disorders [Feb-16-22 09:00AM] Pacific Biosciences Shares Fall As Q4 Earnings Miss Estimates [Feb-16-22 06:03AM] PacBio's (PACB) Q4 Earnings Miss Estimates, Revenues Top [Feb-16-22 09:53AM]
02-11-2021	AH	4:05 PM ET (Nov 2)	PACB	Pacific Biosciences of California, Inc.	5,850	-0.23	-0.21	-0.14	Pacific Biosciences of California EPS beats by $0.01, beats on revenue [11/2/2021 4:10 PM]	29.53	1.58 (5.65%)	29.00	1.05 (3.76%)	11.22 - 53.69	3,354,574	1,750,000	45,013
Pacific Biosciences of California EPS beats by $0.01, beats on revenue [11/2/2021 4:10 PM] PacBio swings to Q3 2021 net gain on 83% YOY revenue increase [11/2/2021 5:19 PM] PacBio Announces Third Quarter 2021 Financial Results [Nov-02-21 04:05PM] PacBios Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare [Nov-02-21 04:03PM] Pacific Biosciences of California (PACB) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-21 05:55PM] Pacific Biosciences of California (PACB) Q3 2021 Earnings Call Transcript [Nov-03-21 04:01AM] PacBio's (PACB) Q3 Earnings Miss Estimates, Revenues Top [Nov-03-21 08:34AM]
03-08-2021	AH	4:05 PM ET (Aug 3)	PACB	Pacific Biosciences of California, Inc.	6,400	-0.21	-0.20	-0.15	Pacific Biosciences of California EPS in-line, beats on revenue [8/3/2021 4:07 PM]	32.13	1.92 (6.36%)	32.13	0.0 (0.00%)	3.74 - 53.69	3,200,530	2,390,000	36,705
Pacific Biosciences acquires DNA extraction company Circulomics [8/3/2021 8:25 AM] Pacific Biosciences of California EPS in-line, beats on revenue [8/3/2021 4:07 PM] Pacific Biosciences posts revenue beat even as net loss widens amid rising SG&A expenses [8/3/2021 5:21 PM] SoftBank builds $5B stake in Roche - Bloomberg [8/4/2021 1:01 PM] Pacific Biosciences Acquires Circulomics A Leading High Molecular Weight DNA Extraction Company [Aug-03-21 08:00AM] Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results [Aug-03-21 04:05PM] SoftBank Builds a $5 Billion Stake in Pharma Giant Roche [Aug-03-21 04:10PM] Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-21 05:25PM] $5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 Years [Aug-04-21 06:45AM] Pacific Biosciences of California (PACB) Q2 2021 Earnings Call Transcript [Aug-04-21 09:31AM] Pacific Biosciences Q2 Earnings Beat Expectations, Higher Operating Costs Widens Quarterly Loss [Aug-04-21 06:52AM] PacBio's (PACB) Q2 Earnings Miss Estimates, Revenues Top [Aug-04-21 11:26AM]
29-04-2021	AH	4:00 PM ET (Apr 29)	PACB	Pacific Biosciences of California, Inc.	6,300	-0.18	-0.45	-0.16	Pacific Biosciences of California EPS beats by $0.01, beats on revenue [4/29/2021 4:17 PM]	29.75	-3.73 (-11.14%)	30.30	-3.18 (-9.50%)	3.13 - 53.69	5,741,929	2,500,000	16,254
Pacific Biosciences of California EPS beats by $0.01, beats on revenue [4/29/2021 4:17 PM] Pacific Biosciences of California, Inc. to Host Earnings Call [Apr-29-21 02:30PM] Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results [Apr-29-21 04:05PM] Pacific Biosciences of California (PACB) Q1 2021 Earnings Call Transcript [Apr-30-21 06:31AM] Why Pacific Biosciences of California Stock Is Down Today [Apr-30-21 12:59PM] Is Pacific Biosciences of California (PACB) A Good Investment Choice? [Apr-30-21 01:22PM]
10-02-2021	AH	4:00 PM ET (Feb 10)	PACB	Pacific Biosciences of California, Inc.	7,240	-0.01	0.43	0.00	Pacific Biosciences of California EPS beats by $0.06, beats on revenue [2/10/2021 4:06 PM]	51.13	5.23 (11.39%)	50.50	4.60 (10.02%)	2.20 - 53.69	8,590,960	4,149,198	82,787
Pacific Biosciences of California EPS beats by $0.06, beats on revenue [2/10/2021 4:06 PM] Pacific BioSciences gains after report of SoftBank $900m investment [2/10/2021 6:23 AM] Pacific Biosciences upgraded to overweight at Piper Sandler [2/11/2021 8:59 AM] Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates [Feb-11-21 12:24PM] How Pacific Biosciences Beat Expectations in Q4 [Feb-11-21 06:00AM] Pacific Biosciences of California (PACB) Q4 2020 Earnings Call Transcript [Feb-10-21 09:31PM] Pacific Biosciences of California, Inc. to Host Earnings Call [Feb-10-21 02:30PM] Why Pacific Biosciences of California Stock Is Soaring Today [Feb-10-21 12:26PM] Pacific Biosciences stock rockets ahead of earnings, after Softbank makes $900 million investment [Feb-10-21 10:28AM] SoftBank to invest $900 million in gene sequencing firm Pacific Biosciences [Feb-10-21 08:45AM] UPDATE 1-SoftBank to invest $900 mln in gene sequencing firm Pacific Biosciences [Feb-10-21 08:44AM] Pacific Biosciences Rises as SoftBank Invests $900 Million [Feb-10-21 08:41AM] Pacific Biosciences Announces $900 Million Investment from SoftBank to Support Growth Initiatives [Feb-10-21 08:00AM] SoftBank To Invest $900M In Pacific Biosciences - WSJ [Feb-10-21 05:20AM]
02-11-2020	AH	4:00 PM ET (Nov 2)	PACB	Pacific Biosciences of California, Inc.	2,360	-0.14	-0.13	-0.19	Pacific Biosciences of California EPS in-line, misses on revenue [11/2/2020 4:14 PM]	12.69	-0.56 (-4.23%)	11.80	-1.45 (-10.94%)	2.20 - 15.12	9,620,137	3,360,390	54,685

03-08-2020	AH	4:00 PM ET (Aug 3)	PACB	Pacific Biosciences of California, Inc.	580.84	-0.15	-0.19	-0.16	Pacific Biosciences of California EPS beats by $0.03, beats on revenue [8/3/2020 4:06 PM]	3.90	0.0 (-0.13%)	3.77	-0.14 (-3.58%)	2.20 - 5.94	444,442	954,407	1,575

06-05-2020	AH		PACB	Pacific Biosciences of California, Inc.	516.07	-0.16	-0.15	-0.20		0.0	0.0 (0.00%)	0.0	0.0 (0.00%)	0.0 - 0.0	0	0	0